For the second year running, physician turnover remains at the highest rate since 2005, according to a report published by the American Medical Group Association.
For physicians trying to balance various financial and time pressures, ethical dilemmas are common, according to an article published Aug. 7 in Medical Economics.
New Classification System for Chronic Obstructive Pulmonary Disease Reflects Updated Assessment and Therapy
By Jackie Syrop
Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death in the United States, and of the top 5 causes of death, it is the only one that increased in incidence between 2007 and 2010, and our understanding of how to assess, manage, and treat COPD has advanced significantly over the past decade.
Continuous positive airway pressure (CPAP) is an effective treatment for daytime sleepiness in seniors with sleep apnea, according to a new study published online Aug. 27 in The Lancet Respiratory Medicine.
By Jackie Syrop
Using the metric of time to first cigarette after waking was found to help improve efficiency and reduce false-positive detection in lung cancer screening, a new case-control study suggests.
The rate of transmission of the Middle East respiratory syndrome coronavirus from patients to household contacts is about 5%, according to research published in the Aug. 28 issue of the New England Journal of Medicine.
The increasing administrative requirements of a medical practice are requiring a team-based approach to care, and physicians must learn to manage the team, according to an article published Aug. 7 in Medical Economics.
By Gale Scott
The nation’s youth, and its smoke-free air need federal protection from vapors from e-cigarettes, according to a set of recommendations released Aug. 25 by the American and Heart Association.
Although confusional arousals are common in the general population, they may be associated with other factors, such as medication consumption, sleep disorders, and mental disorders, according to research published in the Aug. 26 issue of Neurology.
By Jacquelyn Gray
The intravenous respiratory stimulant GAL-021 is effective in treating opioid-induced respiratory depression, according to the results of a small study.